Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).

被引：3
|
作者：
Feldman, T. [1 ]
Mato, A. R. [1 ]
Zielonka, T. [1 ]
Masood, A. [1 ]
Goldberg, S. [1 ]
Rowley, S. D. [1 ]
Donato, M. [1 ]
Siegel, D. S. [1 ]
Pecora, A. [1 ]
Goy, A. [1 ]
机构：
[1] Hackensack Univ, Med Ctr, Hackensack, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.8067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8067
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Espinouse, D
    Michallet, AS
    Traulle, C
    Bouafia-Sauvy, F
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    CANCER, 2005, 104 (07) : 1434 - 1441
  • [22] Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy
    Vigouroux, S
    Milpied, N
    Andrieu, JM
    Colonna, P
    Ifrah, N
    Colombat, P
    Desablens, B
    Abgrall, JF
    Casassus, P
    Guilhot, F
    Briere, J
    Le Mevel, A
    Moreau, P
    Mechinaud, F
    Mahe, B
    Morineau, N
    Vigier, M
    Rapp, MJ
    Harousseau, JL
    BONE MARROW TRANSPLANTATION, 2002, 29 (10) : 833 - 842
  • [23] Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
    Mangel, J
    Buckstein, R
    Imrie, K
    Spaner, D
    Crump, M
    Tompkins, K
    Reis, M
    Perez-Ordonez, B
    Deodhare, S
    Romans, R
    Pennell, N
    Robinson, JB
    Hewitt, K
    Richardson, P
    Lima, A
    Pavlin, P
    Berinstein, NL
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 56 - 69
  • [24] Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy
    S Vigouroux
    N Milpied
    JM Andrieu
    P Colonna
    N Ifrah
    P Colombat
    B Desablens
    JF Abgrall
    P Casassus
    F Guilhot
    J Briere
    A Le Mevel
    P Moreau
    F Mechinaud
    B Mahe
    N Morineau
    M Vigier
    MJ Rapp
    JL Harousseau
    Bone Marrow Transplantation, 2002, 29 : 833 - 842
  • [25] High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results
    Carella, Angelo Michele
    Bellei, Monica
    Brice, Pauline
    Gisselbrecht, Christian
    Visani, Giuseppe
    Colombat, Philippe
    Fabbiano, Francesco
    Donelli, Amedea
    Luminari, Stefano
    Feugier, Pierre
    Browett, Peter
    Hagberg, Hans
    Federico, Massimo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 146 - 148
  • [26] Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma
    Laudi, Noel
    Arora, Mukta
    Burns, Linda
    McGlave, Philip
    Miller, Jeffrey
    Bohac, Gerald
    Rogers, Tyson
    Barker, Juliet
    Coad, James
    Weisdorf, Daniel
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 519 - 524
  • [27] High-dose therapy (HDT) with stem cell transplantation (BMT) for mantle cell lymphoma (MCL):: Results and prognostic factors.: A single center experience.
    Milpied, N
    Gaillard, F
    Moreau, P
    Mahé, B
    Souchet, J
    Rapp, MJ
    Bulabois, CE
    Morineau, N
    Harousseau, JL
    BONE MARROW TRANSPLANTATION, 1998, 21 : S173 - S173
  • [28] High-dose therapy (HDT) with stem cell transplantation (BMT) for mantle cell lymphoma (MCL): Results and prognostic factors. A single center experience.
    Milpied, N
    Gaillard, F
    Moreau, P
    Mahe, B
    Souchet, J
    Rapp, MJ
    Bulabois, CE
    Morineau, N
    Harousseau, JL
    BLOOD, 1997, 90 (10) : 1693 - 1693
  • [29] Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma
    Shafey, Mona
    Duan, Qiuli
    Russell, James
    Duggan, Peter
    Balogh, Alex
    Stewart, Douglas A.
    LEUKEMIA & LYMPHOMA, 2012, 53 (04) : 596 - 602
  • [30] High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
    S Ingen-Housz-Oro
    H Bachelez
    O Verola
    C Lebbé
    J P Marolleau
    C Hennequin
    L Dubertret
    P Morel
    C Gisselbrecht
    P Brice
    Bone Marrow Transplantation, 2004, 33 : 629 - 634
12345